Publication | Open Access

Performance of PD-L1 immunohistochemistry (IHC) assays in unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC): Post-hoc analysis of IMpassion130

Breast OncologyHealth SciencesMedicinePathologyPost-hoc AnalysisImmune Checkpoint InhibitorBreast CancerCancer TreatmentOncologyRadiation OncologyMolecular OncologyRadiologyPd-l1 Immunohistochemistry